Long Live Fully Active Regimens

Discussion in 'HIV reps' started by Anonymous, Aug 27, 2008 at 9:34 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    As the first offical HIV post, I'd like to reinforce a few points from the new IAS clinical guidelines. First, long live regimens based upon a boosted PI. Second, protect Isentress due to it's low genetic barrier to resistance. Third, use Intelence with a strong backbone due to potential archived mutations. Last, it is essential to perform a tropism test if you intend to use Selzentry.
     
  2. Anonymous

    Anonymous Guest

    This is a very interesting industry. I am in specialty another division, can you tell about your experience in this industry and what you do? I would like to consider this option career wise
     
  3. Anonymous

    Anonymous Guest

    You don't want to be in this field
     
  4. Anonymous

    Anonymous Guest

    Agreed, most industries are backing off investment.
     
  5. Howard

    Howard Guest

    Why would you not recommend a career? It's a fascinating therapy area. Unfortunately, the number of patients living with HIV continues to grow, so there will be an ongoing need for new drugs, surely?
     
  6. Anonymous

    Anonymous Guest

    Patient adherence to the prescribed regimen is the key factor for the development of reistance and need for new drugs. Side effects influence this as well. There are a lot of good drugs that work and the newer drug give great efficacy with tolerability. The need for newer drugs may decrease along with profitability. This is why drug companies are scaling back.
     
  7. hermione

    hermione Guest

    Are these ARV's?
    What's the expected prognosis of a full blown patient when having these regimen?